Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search


6 life changing surgeries in 5 days

5 June 2018

New Zealand’s first and only Auditory Brainstem Implant (ABI) Programme inaugurates with 6 life changing surgeries in 5 days

For the very first time in New Zealand, the expertise and skills required to undertake the pioneering auditory brainstem implant surgery is now available through the exclusive ABI Programme offered by Dr Michel Neeff, (FRACS, Neurotologist / Skull Base Surgeon, Cochlear Implant Surgeon, Clinical Director Starship Children's Hospital, Director ENT Associates ) and his team, including neurosurgeon Dr Peter Heppner.

Until now, anyone requiring this life changing surgery has faced extensive overseas travel, which for many has placed this procedure significantly out of reach.

“ABI surgery is the standard of care for hearing rehabilitation in NF2 in most developed countries. There are also non-tumour patients who cannot be rehabilitated by any other means. We have the expertise and skill in NZ now. No patient who meets criteria for brainstem implantation should miss out on this opportunity.” Dr Michel Neeff

Dr Neeff first observed the difference an ABI could make to patients during his fellowship in the UK in 2006. It was on his return to NZ when he observed little support for the device/surgery, noting that even today there remains little funding for it. It was his persistence and determination however, after coming across many suitable candidates in his daily practice who could benefit, desperate to be able to hear even a little, that prompted him to apply for both special funding as well as engage in specialist training in Fulda, Germany by Prof Behr. The excellent hearing outcome of the first patient (2014) provided the encouragement to support further patients in receiving ABIs.

In the programme’s first week (March 2018), 6 life changing surgeries were undertaken with recipients ranging in ages from 4 years to 57 years old, and with varying histories and medical conditions, including vestibular schwannoma (tumour), Goldenhar syndrome and multiple central meningioma’s - all patients receiving a MED-EL Synchrony ABI.

“We developed the MED-EL Synchrony Auditory Brainstem Implant with the aim of improving auditory awareness and communication in patients with non-functioning or absent auditory nerves. An ABI implant can improve the quality of life for patients who are unable to use conventional cochlear implants.” Robyn Shakes, Managing Director, MED-EL Implant Systems Australasia.

Years of planning and lobbying for funding approval culminated in Dr Neeff and his team performing 6 intensive surgeries across a mere 5 days. With two of these patients requiring a tumour removal first, this resulted in very long days, but most importantly in some very successful initial outcomes, including sound detection after 21 years without hearing, a reduction in debilitating tinnitus, hearing mum say hello on the telephone, and man’s best friend barking for the very first time.

“Cochlear Implants and ABIs are life changing devices. To see patients hear again or to learn to hear is extremely rewarding. None of the other senses can be corrected in the way that hearing can. That is special.”

Dr Neeff and his team look forward to supporting other patients who may benefit from this in the future.

About MED-EL

MED-EL Medical Electronics, a leader in implantable hearing solutions, is driven by a mission to overcome hearing loss as a barrier to communication. The Austrian-based, family-owned business was co-founded by industry pioneers Ingeborg and Erwin Hochmair, whose ground-breaking research led to the development of the world’s first micro-electronic multi-channel cochlear implant (CI), which was successfully implanted in 1977 and was the basis for what is known as the modern CI today.

The company offers the widest range of implantable and non-implantable solutions to treat all degrees of hearing loss, enabling people in 117 countries enjoy the gift of hearing with the help of a MED-EL device. MED-EL’s hearing solutions include cochlear and middle ear implant systems, a combined Electric Acoustic Stimulation hearing implant system, auditory brainstem implants as well as surgical and non-surgical bone conduction devices.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Up 0.5%: GDP Growth Eases Slightly

Gross domestic product (GDP) rose 0.5 percent in the March 2018 quarter, Stats NZ said today. This followed a 0.6 percent increase in the December 2017 quarter. Growth in service industries more than offset a fall in construction activity. More>>


Baby Formula: Fonterra Satisfied With Beingmate's Response To Error

Fonterra Cooperative Group is satisfied Beingmate Baby & Child Food is taking the right steps to deal with a labelling issue after getting caught out in a widespread audit by Chinese regulatory authorities. More>>


Adjusted, A Deficit: Current Account Turns To Surplus

New Zealand's current-account turned to a surplus in the first quarter, bolstered by the services balance as tourism remained strong. More>>


Housing: Foreign Buyer Ban Gets Smoother Edges

Amendments to the government’s foreign buyer ban, if introduced, would give overseas investors more leeway to put money into New Zealand housing developments. More>>


Te Kuha: Govt Declines Application To Mine Conservation Land

An application to mine coal on public conservation land near Te Kuha in the Buller District has been declined, Minister of Conservation Eugenie Sage and Minister of Energy Resources Megan Woods announced today. More>>